JP2019523282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523282A5 JP2019523282A5 JP2019505170A JP2019505170A JP2019523282A5 JP 2019523282 A5 JP2019523282 A5 JP 2019523282A5 JP 2019505170 A JP2019505170 A JP 2019505170A JP 2019505170 A JP2019505170 A JP 2019505170A JP 2019523282 A5 JP2019523282 A5 JP 2019523282A5
- Authority
- JP
- Japan
- Prior art keywords
- essential oil
- pharmaceutical composition
- oil
- composition according
- cannabis extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 claims 52
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 241000218236 Cannabis Species 0.000 claims 9
- 150000003505 terpenes Chemical class 0.000 claims 6
- 235000007586 terpenes Nutrition 0.000 claims 6
- 229930003827 cannabinoid Natural products 0.000 claims 5
- 239000003557 cannabinoid Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 5
- NHZMSIOYBVIOAF-UHFFFAOYSA-N 5-hydroxy-2,2-dimethyl-3-(3-oxobutyl)-7-pentyl-3h-chromen-4-one Chemical compound O=C1C(CCC(C)=O)C(C)(C)OC2=CC(CCCCC)=CC(O)=C21 NHZMSIOYBVIOAF-UHFFFAOYSA-N 0.000 claims 4
- 244000165082 Lavanda vera Species 0.000 claims 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims 4
- 244000178231 Rosmarinus officinalis Species 0.000 claims 4
- 239000001102 lavandula vera Substances 0.000 claims 4
- 235000018219 lavender Nutrition 0.000 claims 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims 4
- 208000017520 skin disease Diseases 0.000 claims 4
- 230000000699 topical effect Effects 0.000 claims 4
- 239000004006 olive oil Substances 0.000 claims 3
- 235000008390 olive oil Nutrition 0.000 claims 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N 2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 claims 2
- TWKHUZXSTKISQC-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylphenyl)-5-pentylbenzene-1,3-diol Chemical compound OC1=CC(CCCCC)=CC(O)=C1C1=CC(C)=CC=C1C(C)=C TWKHUZXSTKISQC-UHFFFAOYSA-N 0.000 claims 2
- 241000208983 Arnica Species 0.000 claims 2
- 235000003717 Boswellia sacra Nutrition 0.000 claims 2
- 235000012035 Boswellia serrata Nutrition 0.000 claims 2
- 240000007551 Boswellia serrata Species 0.000 claims 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 2
- 240000004784 Cymbopogon citratus Species 0.000 claims 2
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims 2
- 206010048768 Dermatosis Diseases 0.000 claims 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims 2
- 239000004863 Frankincense Substances 0.000 claims 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims 2
- 244000179970 Monarda didyma Species 0.000 claims 2
- 235000010672 Monarda didyma Nutrition 0.000 claims 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims 2
- 240000002657 Thymus vulgaris Species 0.000 claims 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- 235000013871 bee wax Nutrition 0.000 claims 2
- 239000012166 beeswax Substances 0.000 claims 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene group Chemical group C=CC(CCC=C(C)C)=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 claims 2
- 229930192457 cannabichromanone Natural products 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- 229940065144 cannabinoids Drugs 0.000 claims 2
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 claims 2
- 229960005233 cineole Drugs 0.000 claims 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims 2
- 235000017803 cinnamon Nutrition 0.000 claims 2
- 239000003240 coconut oil Substances 0.000 claims 2
- 235000019864 coconut oil Nutrition 0.000 claims 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- 239000010460 hemp oil Substances 0.000 claims 2
- 235000001510 limonene Nutrition 0.000 claims 2
- 229940087305 limonene Drugs 0.000 claims 2
- 229930007744 linalool Natural products 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims 2
- 235000002020 sage Nutrition 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 239000001585 thymus vulgaris Substances 0.000 claims 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 claims 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 claims 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 claims 1
- 240000006054 Agastache cana Species 0.000 claims 1
- 240000005343 Azadirachta indica Species 0.000 claims 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims 1
- 240000003538 Chamaemelum nobile Species 0.000 claims 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims 1
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 241000675108 Citrus tangerina Species 0.000 claims 1
- 240000007311 Commiphora myrrha Species 0.000 claims 1
- 235000006965 Commiphora myrrha Nutrition 0.000 claims 1
- 244000301850 Cupressus sempervirens Species 0.000 claims 1
- 244000166652 Cymbopogon martinii Species 0.000 claims 1
- 244000004281 Eucalyptus maculata Species 0.000 claims 1
- 240000006927 Foeniculum vulgare Species 0.000 claims 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims 1
- 239000005792 Geraniol Substances 0.000 claims 1
- 241000208152 Geranium Species 0.000 claims 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims 1
- 235000010254 Jasminum officinale Nutrition 0.000 claims 1
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 241000721662 Juniperus Species 0.000 claims 1
- 235000013628 Lantana involucrata Nutrition 0.000 claims 1
- 240000005183 Lantana involucrata Species 0.000 claims 1
- 240000003553 Leptospermum scoparium Species 0.000 claims 1
- 235000015459 Lycium barbarum Nutrition 0.000 claims 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 claims 1
- 241000378467 Melaleuca Species 0.000 claims 1
- 235000013500 Melia azadirachta Nutrition 0.000 claims 1
- 244000062730 Melissa officinalis Species 0.000 claims 1
- 235000010654 Melissa officinalis Nutrition 0.000 claims 1
- 244000246386 Mentha pulegium Species 0.000 claims 1
- 235000016257 Mentha pulegium Nutrition 0.000 claims 1
- 235000004357 Mentha x piperita Nutrition 0.000 claims 1
- 241000499917 Milla Species 0.000 claims 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 claims 1
- 235000007265 Myrrhis odorata Nutrition 0.000 claims 1
- 240000005125 Myrtus communis Species 0.000 claims 1
- 235000013418 Myrtus communis Nutrition 0.000 claims 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims 1
- 240000007817 Olea europaea Species 0.000 claims 1
- 235000011203 Origanum Nutrition 0.000 claims 1
- 240000000783 Origanum majorana Species 0.000 claims 1
- 101100268917 Oryctolagus cuniculus ACOX2 gene Proteins 0.000 claims 1
- 235000011751 Pogostemon cablin Nutrition 0.000 claims 1
- 240000002505 Pogostemon cablin Species 0.000 claims 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 claims 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims 1
- 244000086363 Pterocarpus indicus Species 0.000 claims 1
- 241000220317 Rosa Species 0.000 claims 1
- 235000017304 Ruaghas Nutrition 0.000 claims 1
- 235000002911 Salvia sclarea Nutrition 0.000 claims 1
- 244000182022 Salvia sclarea Species 0.000 claims 1
- 240000000513 Santalum album Species 0.000 claims 1
- 235000008632 Santalum album Nutrition 0.000 claims 1
- UCONUSSAWGCZMV-UHFFFAOYSA-N Tetrahydro-cannabinol-carbonsaeure Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCCCC)C(C(O)=O)=C2O UCONUSSAWGCZMV-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 claims 1
- 229930006739 camphene Natural products 0.000 claims 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 claims 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 claims 1
- RSYBQKUNBFFNDO-UHFFFAOYSA-N caryophyllene oxide Natural products CC1(C)CC2C(=C)CCC3OC3(C)CCC12C RSYBQKUNBFFNDO-UHFFFAOYSA-N 0.000 claims 1
- -1 delta-s-carene Natural products 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229960004242 dronabinol Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- BXWQUXUDAGDUOS-UHFFFAOYSA-N gamma-humulene Natural products CC1=CCCC(C)(C)C=CC(=C)CCC1 BXWQUXUDAGDUOS-UHFFFAOYSA-N 0.000 claims 1
- 229940113087 geraniol Drugs 0.000 claims 1
- 235000001050 hortel pimenta Nutrition 0.000 claims 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims 1
- 150000007823 ocimene derivatives Chemical class 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000008159 sesame oil Substances 0.000 claims 1
- 235000011803 sesame oil Nutrition 0.000 claims 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662370303P | 2016-08-03 | 2016-08-03 | |
| US62/370,303 | 2016-08-03 | ||
| PCT/AU2017/050815 WO2018023164A1 (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019523282A JP2019523282A (ja) | 2019-08-22 |
| JP2019523282A5 true JP2019523282A5 (cg-RX-API-DMAC7.html) | 2020-01-23 |
Family
ID=61072439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019505170A Pending JP2019523282A (ja) | 2016-08-03 | 2017-08-03 | 大麻組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190307719A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3493799A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019523282A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190033590A (cg-RX-API-DMAC7.html) |
| CN (1) | CN109789124A (cg-RX-API-DMAC7.html) |
| AU (5) | AU2017307644B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3031811A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2019000268A1 (cg-RX-API-DMAC7.html) |
| PE (1) | PE20200676A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201900596XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018023164A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3493799A4 (en) | 2016-08-03 | 2020-04-01 | Zelda Therapeutics Operations Pty Ltd | CANNABIS |
| KR102447510B1 (ko) | 2016-08-03 | 2022-09-27 | 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
| KR20210013645A (ko) | 2016-08-03 | 2021-02-04 | 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| US11484510B2 (en) * | 2017-08-28 | 2022-11-01 | Apirx Pharmaceutical Usa, Llc | Method to treat vitiligo |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| EP3793542A4 (en) * | 2018-05-14 | 2022-03-30 | Buzzelet Development And Technologies Ltd | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES |
| US10736869B2 (en) * | 2018-07-16 | 2020-08-11 | ECS Health Sciences, Inc. | Compositions and methods related to cannabinoids, terpenoids and essential oils |
| US11013715B2 (en) * | 2018-07-19 | 2021-05-25 | Vertosa, Inc. | Nanoemulsion hydrophobic substances |
| IL261774B (en) * | 2018-09-13 | 2020-04-30 | Unv Medicine Ltd | Preparations for the treatment of skin problems |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| WO2020086291A1 (en) | 2018-10-22 | 2020-04-30 | Jones Lisa Marie | Topical compositions incorporating cannabis |
| CA3122691A1 (en) * | 2018-12-10 | 2020-06-18 | Natural Extraction Systems, LLC | Compositions with novel cannabinoid and terpene profiles |
| WO2020129044A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis lines and extracts for skin rejuvenation and skin protection |
| WO2020129045A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis lines and extracts for treating skin disorders |
| WO2020129043A1 (en) * | 2018-12-19 | 2020-06-25 | Pathway RX Inc. | Novel cannabis sativa lines and extracts with anti-cancer properties |
| US20220054380A1 (en) * | 2018-12-25 | 2022-02-24 | Epm (Ip), Inc. | Cannabidioloic acid esters for cosmetic or edible compositions |
| EP3906025A4 (en) * | 2019-01-04 | 2022-09-21 | Columbia Care LLC | CANNABINOID TOPICAL FORMULATIONS |
| US11246310B2 (en) * | 2019-02-08 | 2022-02-15 | Global Biolife Inc. | Insect repelling composition |
| US20200345686A1 (en) * | 2019-04-30 | 2020-11-05 | Vcp Ip Holdings, Llc, Limited Liability Company Delaware | Compositions and methods for treating skin and neuropathic conditions and disorders |
| US10717056B1 (en) | 2019-09-09 | 2020-07-21 | Michael Cem Gokay | Method and apparatus for purification of cannabinoid extracts |
| US20210093539A1 (en) * | 2019-09-30 | 2021-04-01 | Concept Matrix Solutions | Topical cosmetic |
| US12343315B2 (en) * | 2019-10-21 | 2025-07-01 | Avicanna Inc. | Topical cannabinoid compositions for clear skin |
| US10941131B1 (en) * | 2019-10-28 | 2021-03-09 | Pure Tonic Concentrates, LLC | Conversion of cannabidiol or delta-9 tetrahydrocannabinolic acid to delta-9 tetrahydrocannabinol and delta-8 tetrahydrocannabinol in nontoxic heterogeneous mixtures |
| US12011471B2 (en) * | 2019-12-19 | 2024-06-18 | Atlas365 Incorporated | Extracts enriched with polyphenolic compounds and related methods |
| WO2021127559A1 (en) * | 2019-12-19 | 2021-06-24 | Natural Extraction Systems, LLC | Compositions comprising cannabinoid anions and anti-nucleating agents |
| WO2021155390A1 (en) * | 2020-01-14 | 2021-08-05 | Shaman Naturals, Llc. | Antimicrobial compositions |
| US20210346276A1 (en) * | 2020-05-05 | 2021-11-11 | Gm Pharmaceuticals, Inc. | Skincare compositions containing cannabidiol |
| US20210369802A1 (en) * | 2020-06-01 | 2021-12-02 | James Chuang | Cannabis plant formulations and methods of delivery |
| US20220054446A1 (en) * | 2020-08-18 | 2022-02-24 | Yvette Rose Webb | Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils |
| DK181329B1 (en) * | 2021-05-04 | 2023-08-16 | Cs Medica As | Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition |
| US20250032567A1 (en) * | 2022-02-13 | 2025-01-30 | Reagenics Research Ltd. | Plant-based skin preparations and use thereof |
| WO2025231524A1 (en) * | 2024-05-08 | 2025-11-13 | Heyday RX Pty Ltd | Cannabinoid compositions |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| JP2004002237A (ja) * | 2002-05-31 | 2004-01-08 | Noriko Yagi | 老化防止ハーブ |
| EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
| US9035130B2 (en) * | 2007-05-31 | 2015-05-19 | Gw Pharma Limited | Reference plant, a method for its production, extracts obtained therefrom and their use |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| ES2541485T3 (es) * | 2010-10-19 | 2015-07-21 | Parenteral, A.S. | Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol |
| US20120264818A1 (en) * | 2011-04-15 | 2012-10-18 | Jon Newland | Topical Compositions with Cannabis Extracts |
| US20130184354A1 (en) * | 2012-01-13 | 2013-07-18 | Donna K. Jackson | Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management |
| US20130274321A1 (en) * | 2012-03-30 | 2013-10-17 | Jon Newland | Topical Compositions with Cannabis Extracts |
| CN104619318A (zh) * | 2012-05-03 | 2015-05-13 | 回音制药公司 | 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法 |
| WO2014100231A1 (en) * | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| US10792318B2 (en) * | 2013-03-14 | 2020-10-06 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
| WO2014145490A2 (en) * | 2013-03-15 | 2014-09-18 | Biotech Institute, Llc | Breeding, production, processing and use of specialty cannabis |
| WO2015048508A1 (en) * | 2013-09-26 | 2015-04-02 | Sekura Ronald D | Topical treatments incorporating cannabis sp. derived botanical drug product |
| HRP20191097T1 (hr) * | 2013-10-29 | 2019-09-20 | Biotech Institute, Llc | Uzgoj, proizvodnja, obrada i upotreba specijalnog kanabisa |
| JP6377423B2 (ja) * | 2014-06-17 | 2018-08-22 | ロート製薬株式会社 | 外用組成物 |
| WO2015200049A1 (en) * | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| US11793769B2 (en) * | 2014-08-25 | 2023-10-24 | Jai Shankar Sukul | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| CA2859930A1 (en) * | 2014-09-22 | 2016-03-22 | Antony Paul Hornby | A cannabis topical from heat treated cocount oil |
| BR112017008301B1 (pt) * | 2014-10-21 | 2021-12-07 | United Cannabis Corp | Extratos de cannabis e métodos de sua preparação e uso |
| US20160309774A1 (en) * | 2015-04-27 | 2016-10-27 | Michael D. Wand | Terpene carrier |
| US10806707B2 (en) * | 2015-11-24 | 2020-10-20 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
| JP6963507B2 (ja) * | 2015-12-09 | 2021-11-10 | ポビバ コーポレーションPoviva Corp. | 脂溶性の活性物質を含む経口摂取可能な組成物を製剤化するための方法 |
| AU2017210319A1 (en) * | 2016-01-20 | 2018-08-23 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
| CA3283924A1 (en) * | 2016-03-16 | 2025-11-29 | Buzzelet Development And Technologies Ltd | Terpene-enriched cannabinoid composition |
| IL246790A0 (en) * | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
| EP3493799A4 (en) | 2016-08-03 | 2020-04-01 | Zelda Therapeutics Operations Pty Ltd | CANNABIS |
-
2017
- 2017-08-03 EP EP17836098.8A patent/EP3493799A4/en not_active Withdrawn
- 2017-08-03 PE PE2019000308A patent/PE20200676A1/es unknown
- 2017-08-03 CA CA3031811A patent/CA3031811A1/en active Pending
- 2017-08-03 KR KR1020197005608A patent/KR20190033590A/ko not_active Ceased
- 2017-08-03 WO PCT/AU2017/050815 patent/WO2018023164A1/en not_active Ceased
- 2017-08-03 CN CN201780060682.7A patent/CN109789124A/zh active Pending
- 2017-08-03 JP JP2019505170A patent/JP2019523282A/ja active Pending
- 2017-08-03 AU AU2017307644A patent/AU2017307644B2/en active Active
- 2017-08-03 US US16/322,898 patent/US20190307719A1/en not_active Abandoned
- 2017-08-03 SG SG11201900596XA patent/SG11201900596XA/en unknown
-
2018
- 2018-07-03 AU AU2018100921A patent/AU2018100921B4/en not_active Expired
-
2019
- 2019-01-31 CL CL2019000268A patent/CL2019000268A1/es unknown
- 2019-07-23 AU AU2019208177A patent/AU2019208177B2/en active Active
-
2021
- 2021-10-01 AU AU2021240296A patent/AU2021240296B2/en active Active
-
2022
- 2022-07-28 US US17/876,071 patent/US20220362208A1/en not_active Abandoned
-
2024
- 2024-05-24 AU AU2024203468A patent/AU2024203468A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523282A5 (cg-RX-API-DMAC7.html) | ||
| AU2021240296B2 (en) | Cannabis Composition | |
| Asif et al. | COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties | |
| JP2021054836A (ja) | 大麻組成物 | |
| JP2020524151A5 (cg-RX-API-DMAC7.html) | ||
| MX2021014158A (es) | Uso de cannabidiol en el tratamiento de espasmos epilepticos. | |
| JP2019523283A5 (cg-RX-API-DMAC7.html) | ||
| JP2019530751A5 (cg-RX-API-DMAC7.html) | ||
| CA2974208A1 (en) | Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler | |
| Thakur et al. | Therapeutic potential of essential oil-based microemulsions: reviewing state-of-the-art | |
| KR20210071941A (ko) | 오피오이드 절약을 위한 조성물 및 방법 | |
| Wang et al. | The genus Schefflera: A review of traditional uses, phytochemistry and pharmacology | |
| BR112021021029A2 (pt) | Preparação de canabidiol, e, método para tratar um paciente que sofre de crises associadas ao complexo de esclerose tuberosa | |
| Aswar et al. | Estrogenic activity of friedelin rich fraction (IND-HE) separated from Cissus quadrangularis and its effect on female sexual function | |
| EP3817735A1 (en) | Cannabinoid composition and method for treating ptsd and/or anxiety | |
| Wang et al. | Toona sinensis fruit polyphenols alleviate cerebral ischemia-reperfusion injury in rats by inhibiting MAPK signaling pathways and NLRP3 inflammasome/pyroptosis | |
| CN105848666A (zh) | 疼痛缓解制剂以及治疗方法 | |
| Azhari et al. | The use of essential oils in atopic dermatitis: a review | |
| Ahn et al. | Anti-inflammatory effects of natural volatile organic compounds from Pinus koraiensis and Larix kaempferi in mouse model | |
| CA3191800A1 (en) | Composition comprising cannabinoids, and/or terpens, and methods of using same | |
| Wazir et al. | Phytochemical analysis and fertility enhancement effects of aerial parts of Fagonia arabica in male and female rats. | |
| Kushwah et al. | Anti-inflammatory potential of some essential oils: A review | |
| Alijanpour et al. | Hawthorn berries ethanolic extract lowered polycystic ovarian syndrome-elevated testosterone level and improved the altered ovaries structure | |
| US20190183956A1 (en) | Use of a clove oil fraction | |
| Adams | Plant Medicines for Clinical Trial |